Inflazyme Pharmaceuticals (T.IZP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Josh C. Pleasure, M.D. who wrote (65)	10/10/1996 11:35:00 PM
From: Sanjay Varma	of 1501

Thanks for the information. It puts things in perspective to have a timetable such as this. I owned Trinity Biotech earlier this year and the stock received a big bounce when they announced a distribution agreement with a large foreign company, Bayer. I was under the impression that Abbott labs would be manufacturing the TB antigen test and so, if this holds true for the upcoming deal, it is not really a distribution agreement but some sort of licensing of patented technology. Still, it will generate a revenue stream. Regarding the submission to the FDA and the start of Phase I trials: I am glad to have these target dates but I have noticed other small biotechs constantly missing these self-imposed deadlines due to the complexity and expense of such submission and trials. I don't know if Inflazyme is better managed in this regard. IMO it would be best for investors not to grow to attached to these targets. Finally, about the Biotechnology fund that might invest in IZP, do you have any figure for the number of new shares they might issue? I fear the stock could go down before it shows any significant return. Thanks again for the great post. Sanjay Varma

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next